Immunochemical analysis of mutant CFTR in lung explants

Area of Science:

• Biochemistry
• Molecular Biology
• Pulmonology

Background:

• Limited data exists on cystic fibrosis transmembrane conductance regulator (CFTR) protein glycoforms in native lung tissue.
• Understanding mutant CFTR protein biochemistry is crucial for developing novel CFTR correctors and potentiators.
• The lung is the primary organ affected in cystic fibrosis (CF).

Purpose of the Study:

• To investigate the abundance and distribution of CFTR protein glycoforms in native lung tissue.
• To assess the feasibility of immunoblot analysis of CFTR in lung tissue for future therapeutic studies.
• To compare the suitability of lung tissue versus rectal biopsies for CFTR studies.

Main Methods:

• Lung tissue samples from CF patients and non-CF donors were analyzed using immunoblotting.
• CFTR-immunoreactive signals were quantified via densitometry.
• Comparison with CFTR detection in rectal biopsies from F508del homozygous subjects.

Main Results:

• All non-CF lung specimens contained complex-glycosylated and mannose-rich CFTR isoforms.
• CF lung samples showed no or only immature CFTR isoforms.
• Mature CFTR was undetectable in end-stage CF lungs, though present in rectal biopsies of some CF patients.

Conclusions:

• Immunoblot analysis of CFTR in lung tissue is technically feasible.
• Rectal biopsies are a more practical and repeatable sample source for studying CFTR protein biochemistry.
• Findings inform the selection of appropriate tissues for upcoming CFTR modulator studies.